A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...

GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...